Zinc of Ireland Limited Overview
Zinc of Ireland is a Perth-headquartered, ASX-listed micro-cap that in 2026 transformed from a single-asset Irish zinc explorer into a hybrid "upstream resource plus downstream metals-technology" company. Upstream, it holds the Kildare Zinc-Lead Project on Ireland's Rathdowney Trend — 17 prospecting licences over 595 km² hosting an Inferred Mineral Resource of 11.3 Mt at 9.0% Zn+Pb, located about 40 km southwest of Dublin. Downstream, through the June 2026 acquisition of Netherlands-based Meclex, it owns two proprietary hydrometallurgical processes: ARGO, which targets recovery of zinc, lead, silver and the critical minerals germanium, gallium and indium from zinc leach residue produced by primary zinc smelters; and VOLTA, a low-temperature lead-acid battery recycling process. Neither technology is commercial (ARGO TRL 4; VOLTA TRL 6), and the company has no revenue. The equity story rests on European critical-minerals and battery regulation, industrial partners (Nyrstar; SERI Industrial/FIB) and a refreshed Perth corporate team.
Company's own description (FY2026 Annual Report)
The FY2026 Annual Report describes the Group's principal activities as the exploration and evaluation of mineral properties in Europe and, following the acquisition of Meclex, the research and development of metal extraction technologies in Europe. The stated objective is to create long-term shareholder value by developing and commercialising its metal extraction technologies and by exploring and developing its mineral deposits, so as to build and scale a new supply of zinc and other critical metals in Europe and globally. The report candidly states that the Group has not yet demonstrated commercial viability of either its technologies or its mineral deposits, and has not reported any Ore Reserves.
Management frames the technologies against four structural pressures facing European heavy industry: extreme energy-price volatility; rising carbon costs and emissions regulation; tightening waste-disposal and recycling legislation; and substantial unrecovered value in zinc, lead, silver and critical minerals lost to residues. ARGO and VOLTA are pitched as low-temperature, low-emission hydrometallurgical alternatives to incumbent high-cost pyrometallurgical processes.
Business model and revenue model
| Dimension | Characterisation |
|---|---|
| Current revenue | Nil (FY2022–FY2026). Only income is interest and FX (FY2026 finance income A$9,891) |
| Intended model — VOLTA | Technology licensing. FY2026 AR states ZMI's strategy is to become a technology licensing company, implementing VOLTA with partners across Europe and globally; discussions with a potential licensee for a greenfield European plant are disclosed. Revenue forms contemplated in the Meclex Incentive Plan definition: sales, operations, licensing fees, royalties |
| Intended model — ARGO | Not finalised. Pathway is testwork → pilot plant (targeted early 2027) → commercial demonstration plant → licensing / deployment at smelters; pre-engineering for a 100,000 tpa commercial plant has commenced |
| Intended model — Kildare | Conventional mine development (scoping study → PFS → development) and/or sale; ARGO integration intended to improve concentrate value |
| Product vs service vs licensing mix | 0% / 0% / 0% today; prospective mix weighted to licensing/royalties (technology) and commodity sales (Kildare, long-dated) |
Value-chain position
ZMI is unusual among ASX juniors in deliberately straddling the zinc value chain: (1) upstream mineral exploration (Kildare zinc-lead-silver, with germanium/gallium potential under investigation); (2) midstream process technology for primary zinc refiners (ARGO, treating zinc leach residue — a waste stream of the roast-leach-electrowinning route); and (3) secondary/circular metals (VOLTA, treating spent lead-acid batteries for secondary lead smelters). The FY2026 AR explicitly notes ARGO has direct application to smelter residues generated from concentrates such as those Kildare would produce.
Target customers and end-markets
| Offering | Customer type | End-market |
|---|---|---|
| ARGO | Primary zinc smelters/refiners (e.g., Nyrstar — partner and feedstock provider) | Zinc and lead metal; silver; critical minerals (Ge, Ga, In) for semiconductors, fibre optics, infrared optics, LEDs/solar, defence |
| VOLTA | Secondary lead smelters / lead-acid battery recyclers (e.g., SERI Industrial/FIB in Italy; several European recyclers expressing interest per FY2026 AR) | Lead-acid battery recycling (automotive SLI, industrial batteries) |
| Kildare | Future concentrate buyers (smelters) or acquirers | Zinc and lead concentrates |
Independent characterisation
In substance ZMI is a pre-revenue, early-stage technology-development company with an option-value exploration asset attached. The A$5.58m carrying value of the acquired IP (ARGO A$3.91m; VOLTA A$1.67m) and A$8.96m of capitalised Kildare exploration together make up 77.6% of total assets (FY2026). The company's near-term value drivers are technical (testwork results, pilot/demo plant commissioning, Kildare assays) and contractual (formal extension of the VOLTA cooperation arrangement with FIB/SERI, scope of the Nyrstar ARGO cooperation, first licence agreement), rather than financial. Funding is entirely equity-based and highly dilutive; the capital structure carries a very large overhang of vendor performance rights and incentive options.
Strategy
Stated strategy (FY2026 Annual Report themes)
Management's medium-to-long-term strategy, as listed in the FY2026 AR, comprises seven pillars: (1) continue testing to take ARGO to pilot phase; (2) commission the VOLTA commercial demonstration plant; (3) design and commission an ARGO commercial demonstration plant; (4) continue R&D into alternative applications of ARGO and VOLTA; (5) pursue commercial licensing discussions with potential customers; (6) continue exploring for zinc and additional critical minerals at Kildare; and (7) complete a Kildare Scoping Study. The CEO's letter adds the aim of aligning milestones with partners' project timelines and positioning for larger-scale European funding opportunities in 2027 and beyond.
Initiative register (last 24 months)
| Date | Initiative | Type | Target / status |
|---|---|---|---|
| FY2025 | Entitlement offer and placements (A$2.5m) | Funding | Completed |
| FY2025 | Acquisition of Mt Clere earn-in (15m shares) | Portfolio | Exited and impaired FY2026 |
| 9 Apr 2026 | Acquisition of Meclex | Transformation | Completed 16 Jun 2026 |
| 9 Apr 2026 | Leadership refresh (CEO, Chair, CFO, CTA) | Organisation | Completed Apr–Jun 2026 |
| Apr–Jun 2026 | A$5.5m two-tranche placement | Funding | Completed 22 Jun 2026 |
| Jul 2026 | Kildare 3,500 m drilling (Phase One) | Exploration | Running to Q1 CY2027 |
| Jul 2026 | Conversion to company limited by shares; rename | Corporate | Completed 23 Jul 2026 |
| Aug 2026 | ARGO testwork acceleration focused on Ge/Ga/In; pilot pulled forward to early 2027 | Technology | In progress |
| Aug 2026 | VLAIO €734k grant | Non-dilutive funding | Awarded |
| FY2026–27 | Expanded Nyrstar collaboration agreement | Partnership | Expanded (per CEO letter) |
| 2,026 | Pre-engineering for 100,000 tpa ARGO commercial plant | Technology | Commenced |
| 2,026 | VOLTA demo plant at Calitri; mobile pilot unit | Technology | Commissioning targeted Q4 2026 |
| 2,026 | VOLTA licence discussions for European greenfield plant | Commercial | Negotiation stage |
| Oct 2026 | A$3.24m placement for ARGO testwork, ARGO techno-economic study, VOLTA pilot commissioning, Kildare critical-minerals evaluation | Funding | Shares issued ~16 Oct 2026 |
Guidance and targets
| Item | Management target |
|---|---|
| ARGO critical-minerals testwork | Complete in H1 2027 |
| ARGO scaled pilot plant | Early 2027 (subject to results) |
| VOLTA commercial-scale demo plant | First commissioning Q4 2026 |
| VOLTA commercialisation in Europe | From late 2026 |
| Kildare Phase One drilling | Through Q1 CY2027 |
| Kildare Scoping Study | Planned; no date given |
| Financial targets (revenue, margins) | None provided |
| ESG / emissions targets | None provided |
Products & Services
ARGO technology (Metals Technologies)
| Attribute | Detail |
|---|---|
| Description | Hydrometallurgical process to recover zinc, lead, silver and potentially gallium, germanium and indium from Zinc Leach Residue (ZLR) generated in primary zinc smelting/refining |
| Claimed advantages (FY2026 AR) | Higher recoveries of Zn, Pb, Ag and potentially critical minerals; lower energy use; lower CO2 and gaseous toxic-metal emissions; stable, inert waste product reducing disposal liabilities; potential to raise concentrate value and improve economics of projects such as Kildare |
| Technology readiness | TRL 4 (FY2026 AR risk section). Key process steps previously demonstrated at lab (batch) scale on distinct industrial ZLR samples |
| Testwork | Major programme at Solvomet (KU Leuven's research centre for circular hydrometallurgy, Belgium) and Core Resources (Australia); accelerated August 2026 with focus on Ge/Ga/In |
| Results to date | Screening leach tests on ZLR from three European smelters (3 Sep 2026): up to 99% silver, up to 100% lead and 91% copper reporting to leachate; zinc leach recoveries in the published table appear in the 35–70% range. Critical-mineral results pending. FY2026 AR cites consistent separation rates across all three feedstocks |
| Scale-up | Simulation testing to build full-circuit model for a 100,000+ tpa installation; pre-engineering commenced; scaled pilot plant targeted early 2027 (earlier guidance mid-2027) |
| Partners | Nyrstar (cooperation agreement: feedstock, know-how, testing facilities; non-exclusive; all IP stays with Meclex) |
| Funding | €734,000 (~A$1.2m) VLAIO grant (Aug 2026); proceeds of Oct 2026 placement for testwork and a techno-economic study |
| IP | Primary patents/applications with remaining useful lives of 14–21 years (Group-level disclosure, FY2026 AR Note 1(k)); patent numbers/jurisdictions not itemised publicly |
| Carrying value | A$3,906,058 at 30 June 2026 |
| Pricing model | — |
VOLTA technology (Metals Technologies)
| Attribute | Detail |
|---|---|
| Description | Low-energy, low-temperature hydrometallurgical lead-acid battery recycling process intended to replace high-temperature secondary lead smelting |
| Claimed advantages | Elimination of toxic gases; significant CO2 reduction; ultra-high recoveries (currently >99% lead, versus the EU Battery Regulation's 90% lead-recovery requirement from December 2027); significant waste reduction |
| Technology readiness | TRL 6 (FY2026 AR); demonstration programme intended to pass TRL 7, with pathway to TRL 8 |
| Prior validation | Previously tested by FIB S.p.A. (controlled by SERI Industrial S.p.A.), with key benefits verified in operation |
| Development plan | Smaller pilot phase bypassed in favour of a larger commercial-scale demonstration plant adjacent to SERI's recycling plant in Calitri, southern Italy; first commissioning targeted Q4 2026 (delayed by additional regulatory approvals for the larger scale). Parallel development of a low-cost mobile/modular pilot unit for on-site testing at customers' secondary lead facilities |
| Commercial | Licensing model; discussions with a potential licensee for a greenfield European plant; interest from several European lead recyclers; commercialisation across Europe planned from late 2026 aligned with EU Battery Regulation rollout |
| Contractual status | VOLTA Cooperation Agreement with FIB expired 31 August 2026; extension under negotiation. Meclex retains IP and access to non-EU markets under the agreement; FIB/SERI provides demonstration-plant infrastructure, engineering and funding |
| Carrying value | A$1,672,858 at 30 June 2026 |
| Incentive linkage | Meclex Incentive Plan: up to 20% of VOLTA net cash flows paid annually to eligible Meclex staff for FY2027–FY2029 |
Kildare Zinc-Lead Project (Mineral Exploration)
| Attribute | Detail |
|---|---|
| Location | ~40 km SW of Dublin, Ireland; Rathdowney Trend |
| Tenure | 17 Prospecting Licences, 595 km², ~50 km of prospective strike (FY2026 AR). Older descriptions cite ~240 km² of contiguous licences (aggregators — likely pre-dating licence additions) |
| Resource | Inferred MRE 11.3 Mt at 9.0% Zn+Pb (no Ore Reserves) |
| Resource history | Jun 2017: 5.2 Mt at 8.6% Zn+Pb → c.2019: 743 kt Zn + 116 kt Pb contained (8.2% Zn, 1.3% Pb; 5.5% ZnEq cut-off) → c.2020: 11.3 Mt at 9% Zn+Pb |
| Geology | Irish-Type Zn/Pb; McGregor and Shamrock zones; Allenwood Graben; thick, flat-lying zone >20 m reported historically as amenable to efficient mining |
| Current work | ~3,500 m diamond drilling from July 2026 (Phase One to Q1 CY2027) testing extensions and regional step-outs; sampling for Ge, Ga, In; samples for ARGO integration testwork. April 2026 announcement referred to 4,000 m — subsequently revised to 3,500 m |
| Next study | Scoping Study planned (FY2026 AR strategy list); Class C vendor rights tied to a PFS showing post-tax NPV ≥ A$200m and IRR ≥ 20% with ARGO integration |
| Carrying value | A$8,955,685 (after A$145,847 impairment of certain tenements in FY2026) |
Exited / non-core assets
| Asset | Status |
|---|---|
| Mt Clere (WA) — earn-in, Zn/Pb/Cu/Au | Withdrawn from earn-in; fully impaired (A$274,400) in FY2026 |
| Murchison gold (WA) — tenement application | Application withdrawn |
| Earaheedy (Zn/Pb/Ag) and Cascade (REE), WA | Historical projects referenced in aggregator profiles; current status not disclosed in FY2026 AR (not listed as areas of interest) |
Financial Narrative
Income statement
Margins (gross, operating, EBITDA, net) and revenue CAGR are not meaningful given zero revenue in every year.
Commentary. The FY2026 statutory loss of A$4.41m (FY2025: A$1.81m) is dominated by a non-cash A$3.04m share-based payment charge arising from the incentive packages granted to the new chair, CEO, CFO, directors and Meclex-linked staff. Stripping out SBP and impairments, the underlying cash-type operating cost base actually fell from roughly A$1.26m to A$0.94m, chiefly because far less exploration was expensed (A$0.05m vs A$0.56m) while the company was negotiating the Meclex transaction. Business development cost tripled (A$0.21m vs A$0.07m), reflecting deal work. The R&D line (A$0.06m) captures only two weeks of Meclex ownership; FY2027 R&D will step up materially with the expanded ARGO testwork, VOLTA mobile pilot unit and techno-economic study. Corporate cost is set to rise from FY2027 because Apollo Group Pty Ltd (a Pearce-related entity) receives a A$22,500 monthly retainer (≈A$270,000 p.a.) from 1 July 2026, and the CEO's fixed remuneration is A$300,000 p.a.
Balance sheet
FY2023 cash is implied from an aggregator net-debt figure (Stoxray); FY2023 equity from InvestSMART. FY2024 cash, E&E, equity and accumulated losses are opening balances disclosed in the FY2026 AR.
Commentary. The balance sheet is debt-free and simple: cash, capitalised exploration and acquired IP, offset by modest trade payables. Net assets rose 82% to A$18.18m in FY2026 as A$5.5m of placement equity and A$4.53m of acquisition equity (shares plus Class A performance rights) more than offset the loss. The A$5.59m IP value was established through asset-acquisition accounting (no goodwill), with the excess of consideration over net tangible liabilities (A$0.84m, largely a pre-acquisition loan from ZMI to Meclex) allocated to the technologies. Investors should note that Class B and Class C vendor rights were valued at nil because management could not judge their milestones probable; should those milestones become probable, they would add to the share count but — under asset-acquisition accounting — not retrospectively to the IP carrying value without reassessment.
Cash flow
Commentary. FY2026 cash burn (operating + exploration + acquisition) was A$2.65m. Operating outflows tripled to A$1.27m, partly because FY2025 had benefited from a A$0.84m build in payables that partially unwound (-A$0.37m) in FY2026. The company bridged to the June 2026 raise using a A$200,000 unsecured, interest-free loan from director Tom Corr, repaid before year-end. Post year-end, funding was supplemented by the €734k VLAIO grant (receipt timing not disclosed) and A$3.24m gross from the October 2026 placement. Pro-forma liquidity in mid-October 2026 is not disclosed; the September 2026 quarterly (due ~29 October 2026) will provide the next cash print.
Ratios
ROIC, net debt/EBITDA, interest coverage and cash conversion cycle are not meaningful for a pre-revenue, debt-free entity. Aggregator ROE (InvestSMART, end-equity basis): FY2023 -5.1%, FY2024 -19.5%, FY2025 -18.1%.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Jurisdiction | Function |
|---|---|---|
Zinc of Ireland Limited | Australia | Listed parent; corporate, finance, capital markets |
Metallon Clean Extractions BV (Meclex) | Netherlands | Owns ARGO and VOLTA IP; technology development; grant recipient (VLAIO); holds cooperation agreements with Nyrstar (ARGO) and FIB S.p.A. (VOLTA) |
Irish exploration subsidiary(ies) holding Kildare prospecting licences (originating from the 2016 acquisition of Zinc Mines of Ireland Limited) | Ireland | — |
Segment Revenue
| Economic activity | Contents | Key FY2026 balance-sheet value (AUD Mn) | FY2026 directly attributable expense disclosed (AUD Mn) |
|---|---|---|---|
Metals Technologies — ARGO | Zinc leach residue processing | 3.91 (intangible) | R&D 0.06 (total Group, both technologies; post-acquisition only) |
Metals Technologies — VOLTA | Lead-acid battery recycling | 1.67 (intangible) | (included above) |
Mineral Exploration — Kildare | 17 PLs, Ireland | 8.96 (E&E asset) | Exploration expensed 0.05; impairment 0.15 |
Mineral Exploration — WA (exited) | Mt Clere earn-in; Murchison application | 0.00 (fully impaired A$0.27m) | Impairment 0.27 |
Segment Revenue (FY2024–FY2026)
| Segment | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Mineral exploration revenue (AUD Mn) | 0 | 0 | 0 |
Metals technologies revenue (AUD Mn) | 0 | 0 | 0 |
Total revenue (AUD Mn) | 0 | 0 | 0 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Gross profit (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Exploration and evaluation expensed (AUD Mn) | — | — | — | 0.56 | 0.05 |
Research and development expense (AUD Mn) | — | — | — | 0.00 | 0.06 |
Corporate and administrative expense (AUD Mn) | — | — | — | 0.63 | 0.61 |
Business development expense (AUD Mn) | — | — | — | 0.07 | 0.21 |
Share-based payment expense (AUD Mn) | — | — | — | 0.16 | 3.04 |
Impairment of exploration assets (AUD Mn) | — | — | — | 0.39 | 0.42 |
Operating income / EBIT (AUD Mn) | — | — | — | -1.81 | -4.42 |
EBITDA (AUD Mn) | — | — | — | -1.81 | -4.41 |
Adjusted EBITDA ex-SBP and impairment (AUD Mn) | — | — | — | -1.26 | -0.94 |
Pre-tax income (AUD Mn) | — | -0.53 | -1.67 | -1.81 | -4.41 |
Net income (AUD Mn) | — | -0.53 | -1.67 | -1.81 | -4.41 |
EPS basic (A$ cents) | — | -0.2 | -0.6 | -0.4 | -0.7 |
EPS diluted (A$ cents) | — | -0.2 | -0.6 | -0.4 | -0.7 |
Dividends per share (A$ cents) | 0 | 0 | 0 | 0 | 0 |
Balance Sheet and Share Count (M)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | — | — | — | 10.64 | 18.73 |
Cash and equivalents (AUD Mn) | — | 1.60 | 0.33 | 1.25 | 4.11 |
Short-term debt (AUD Mn) | — | 0 | 0 | 0 | 0 |
Long-term debt (AUD Mn) | — | 0 | 0 | 0 | 0 |
Net debt (AUD Mn) | — | -1.60 | -0.33 | -1.25 | -4.11 |
Exploration and evaluation assets (AUD Mn) | — | — | 8.51 | 9.32 | 8.96 |
Goodwill (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Intangible assets (AUD Mn) | 0 | 0 | 0 | 0 | 5.58 |
Total liabilities (AUD Mn) | — | — | — | 0.63 | 0.55 |
Total equity (AUD Mn) | — | 10.30 | 8.57 | 10.01 | 18.18 |
Working capital (AUD Mn) | — | — | — | 0.69 | 3.64 |
Accumulated losses (AUD Mn) | — | — | 9.04 | 10.85 | 14.87 |
Ordinary shares on issue (M) | — | — | 213.1 | 582.0 | 1,285.0 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | — | — | — | -0.40 | -1.27 |
Capex — exploration and evaluation payments (AUD Mn) | — | — | — | -1.06 | -0.37 |
Free cash flow (AUD Mn) | — | — | — | -1.46 | -1.64 |
Acquisition outflow — Meclex (AUD Mn) | — | — | — | 0 | -1.01 |
Equity raised gross (AUD Mn) | — | — | — | 2.49 | 5.50 |
Net borrowings (AUD Mn) | — | — | — | 0 | 0 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on average equity (%) | — | — | — | -19.5 | -31.3 |
ROA on average assets (%) | — | — | — | — | -30.0 |
Current ratio (x) | — | — | — | 2.08 | 7.65 |
Debt / equity (x) | 0 | 0 | 0 | 0 | 0 |
Asset turnover (x) | 0 | 0 | 0 | 0 | 0 |
Geographic Revenue
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Revenue — Australia (AUD Mn) | 0 | 0 | 0 |
Revenue — Europe (AUD Mn) | 0 | 0 | 0 |
Revenue — Other (AUD Mn) | 0 | 0 | 0 |
Valuation Snapshot
| Metric | Value | Source / basis |
|---|---|---|
Latest price | 0.020 | 8 Oct 2026 (Grafa) |
Price at FY2025 AR release (22 Sep 2025) | 0.009 | InvestSMART announcement list |
1-year change | ≈ +122% | 0.009 → 0.020 |
Placement prices | 0.010 (Jun 2026); 0.018 (Oct 2026) | FY2026 AR; Kalkine |
Price around Meclex announcement | 0.018 (9 Apr 2026) | InvestSMART |
Low point of 52 weeks prior to deal | ~0.007–0.008 (2025) | Simply Wall St / InvestSMART |
3-year change | Not precisely verifiable; Simply Wall St reported -69.7% (3-yr) and -78.3% (5-yr) at a A$0.01 price in 2025; the subsequent doubling leaves the 3- and 5-year returns still negative | Aggregator |
Metric | FY2022 | FY2023 |
Valuation Multiples
| Multiple | ZMI |
|---|---|
P/E | n/m (loss-making) |
EV/EBITDA | n/m |
EV/Sales | n/m |
P/B | ≈1.6x (A$29m market cap / A$18.2m FY2026 net assets; pre-Oct raise book) |
EV | ≈ A$25m (A$29m less ~A$4.1m 30 Jun cash, before Oct raise and subsequent burn) |
EV / Kildare contained Zn+Pb | Not meaningful given technology value mix |
Capital Markets
| Item | Status |
|---|---|
Analyst coverage / consensus | None (Simply Wall St: 0 analysts) |
Dividend history / policy | Never paid; no dividend policy during exploration/R&D phase (FY2026 AR) |
Buybacks | None authorised |
Credit ratings (Moody's/S&P/Fitch) | Not rated |
Debt maturity profile | No debt |
Index membership / ETFs | Not held by any ETF (InvestSMART) |
Securities on Issue
| Security | Number (M) | Terms |
|---|---|---|
Ordinary shares | 1,465.0 | Incl. 180M Oct placement |
Vendor Class A rights | 130.0 | ARGO recovery milestone; exp. Jun 2029 |
Vendor Class B rights | 255.6 | Higher ARGO milestone; exp. Jun 2029 |
Vendor Class C rights | 311.1 | Kildare PFS milestone; exp. Jun 2029 |
Vendor employee options Class A | 85.0 | A$0.02; vest Jun 2028; exp. May 2029 |
Vendor employee options Class B | 85.0 | A$0.03; vest Jun 2028; exp. May 2030 |
Employee rights (A$0.03 VWAP) | 63.5 | Exp. Jun 2031 |
Employee rights (A$0.04 VWAP) | 63.5 | Exp. Jun 2031 |
Employee options A$0.02 | 95.0 | Exp. May 2029 |
Employee options A$0.03 | 95.0 | Exp. May 2030 |
Options A$0.015 | 30.0 | Exp. Dec 2027 |
Options A$0.02 | 5.0 | Exp. May 2028 |
Fully diluted total | 2,683.7 | — |
Analyst Conclusions
Management guidance (summary)
ARGO critical-minerals testwork to complete in H1 2027, with a scaled pilot plant discussed for early 2027; ARGO techno-economic study funded by the October raise; VOLTA commercial-scale demonstration plant first commissioning in Q4 2026 and European commercialisation from late 2026; Kildare Phase One drilling and germanium assays through Q1 CY2027; Kildare Scoping Study planned. No financial guidance. No consensus exists.
Bull case
-
Regulation-driven demand is real and dated. The EU Battery Regulation's 90% lead-recovery requirement from December 2027 and the CRMA's 2030 processing/recycling benchmarks create hard compliance deadlines; VOLTA's reported >99% recovery and ARGO's Ge/Ga/In focus map directly onto them.
-
Partner-funded de-risking. SERI/FIB is building the VOLTA demonstration plant at its own cost, and Nyrstar supplies feedstock and facilities for ARGO — meaning ZMI's A$4–7m of liquidity buys more technical progress than its size implies. Early ARGO results (Ag up to 99%, Pb up to 100%) may already approach the Class A milestone thresholds.
-
Cheap optionality. At ≈A$29m market cap, investors pay roughly 1.6x book for two patented processes (14–21 years of protection) plus an 11.3 Mt Inferred zinc resource that carried A$8.96m of capitalised spend.
Bear case
-
Contract fragility. The VOLTA Cooperation Agreement lapsed on 31 August 2026 and the Nyrstar arrangement is non-exclusive; without formalised, exclusive commercial terms, the route to revenue is uncertain.
-
Dilution machine. Shares outstanding rose ~6.9x in just over two years, raises have been priced at A$0.01–0.018, and ~1.22bn convertible securities could take the diluted count to ~2.7bn — capping per-share upside even on technical success.
-
Disclosure gaps and early TRLs. No feed grades, overall circuit recoveries, capex, opex or unit economics have been published; ARGO sits at TRL 4, and zinc recoveries in the September screening tests were materially lower than lead/silver.
Catalysts and monitorables (next 12 months)
| Expected timing | Catalyst | What to watch |
|---|---|---|
| ~29 Oct 2026 | September 2026 quarterly | Cash balance, burn rate, grant receipt |
| ~12 Nov 2026 | AGM | Remuneration votes; any governance changes (committees) |
| Q4 2026 | VOLTA demo plant first commissioning (Calitri) | Timing vs. guidance; permit status; formal FIB/SERI extension |
| Q4 2026 – Q1 2027 | ARGO critical-mineral (Ge/Ga/In) results | Recovery levels; Class A/B vesting announcements |
| Q4 2026 – Q1 2027 | Kildare assays incl. germanium | Grade/width; Ge content |
| H1 2027 | ARGO techno-economic study | First disclosed economics |
| Early 2027 | ARGO scaled pilot decision with Nyrstar | Funding structure; exclusivity |
| 2,027 | First VOLTA licence agreement | Fee/royalty terms; counterparty quality |
| 2,027 | Larger EU funding applications | Non-dilutive capital |
| Ongoing | Further capital raises | Pricing, discount, attaching options |
Analyst verdict
Zinc of Ireland has executed one of the more coherent reinventions in the ASX micro-cap space in 2026. In the span of roughly ten weeks it replaced its board chair and management, acquired two patented hydrometallurgical processes for an accounting cost of A$4.75m paid almost entirely in paper, raised A$5.5m, renamed itself, and started drilling. The strategic logic — owning both a zinc resource and process technology aimed at the zinc and lead value chain's dirtiest steps — is sound, and timing relative to European critical-minerals and battery regulation is favourable. Industrial partners of the calibre of Nyrstar and SERI/FIB lend credibility that a A$29m company could not otherwise buy, and the September ARGO screening results are an encouraging first data point.
Yet the investment case is, at this stage, almost entirely prospective. There is no revenue, no disclosed process economics, ARGO is at TRL 4, and the most commercially advanced asset, VOLTA, currently sits outside a formal cooperation agreement after its expiry on 31 August 2026. The capital structure is the critical analytical issue: with roughly 1.47bn shares and about 1.22bn performance rights and options outstanding, success scenarios trigger heavy dilution, and failure scenarios require repeated raises at low prices. Governance is lean — no board committees and material related-party service arrangements — which is common for Perth incubator-style vehicles but below institutional standards.
On balance, ZMI should be viewed as a speculative, event-driven technology option rather than a zinc developer. The next six months are unusually catalyst-dense (VOLTA commissioning, ARGO critical-mineral results, Kildare germanium assays, a techno-economic study), and each is binary in character. Our stance: Speculative / Monitor — position sizing appropriate to a pre-revenue venture asset, with formal extension of the FIB/SERI agreement and publication of ARGO unit economics as the two gating items for a more constructive view.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Background / education | Other listed directorships (3 yrs) |
|---|---|---|---|---|
Mark Pearce | Non-Executive Chairman | 15 Apr 2026 | B.Bus, Chartered Accountant, FCIS, FFin; experienced founder/developer of listed resource companies | NGX Ltd; Constellation Resources; GreenX Metals; Equatorial Resources; Sovereign Metals; Terra Metals (alternate, to Jan 2026) |
Thomas (Tom) Corr | Non-Executive Director | 7 Oct 2016 | 20+ years finance/resources in Australia and Europe; Irish-resident; identified and acquired Kildare; founding director/shareholder | — |
Peter Huljich | Non-Executive Director (listed as prior Chairman by MarketScreener) | 8 Mar 2023 | BCom, LLB (UWA), Grad Dip Applied Finance, GAICD, FGIA; ex-Goldman Sachs, Barclays Capital, Lehman Brothers, Macquarie (London); senior negotiator at Industrial Promotion Services (Aga Khan Fund for Economic Development) | Cloudbreak Discovery Plc; Macro Metals (to May 2024) |
Dr Julian Barnes | Non-Executive Director | 23 Aug 2018 | BSc (Hons), PhD, FAusIMM, MAIG; geologist, 35+ years, 52 countries; co-founded RSG (RSG Global) 1986; formerly head of exploration at Dundee Precious Metals; age 72 (MarketScreener) | Thor Explorations; Adriatic Metals (to Jun 2024) |
Calogero (Jerry) Monzu | Former Non-Executive Director | Resigned 20 Mar 2026 | FGIA, CPA, BBus; founder of Capella Corporate Consulting; continues as Joint Company Secretary | — |
Executive Leadership Team
| Name | Role | Appointed | Background |
|---|---|---|---|
Greg Ross | Chief Executive Officer | 9 Apr 2026 | BEng (Mechanical, Curtin), MAICD, MIEAust; 40+ years in engineering, manufacturing, product development; senior roles at Kvaerner and Aker Solutions; previously CEO & MD of KC8 Capture Technologies |
Greg Swan | CFO & Joint Company Secretary | 24 Jun 2026 | BCom (UWA), CA, FCIS, FFin; former CFO/Company Secretary of IperionX (ASX/NASDAQ); prior roles with Piedmont Lithium, Mantra Resources, Papillon Resources; age 45 (MarketScreener); engaged via Apollo Group services agreement |
Martijn Cysouw | General Director, Meclex | 16 Jun 2026 | Meclex principal; consulting fee €141,720 p.a.; 6-month notice |
Dr Duncan Turner | Chief Technical Advisor | FY2026 | Metallurgist/chemist; extractive metallurgy and hydrometallurgy specialist |
Greg Hope | Exploration Manager | — | Geologist, 20+ years; formerly Exploration and Geology Manager at Dalradian Resources (2015–2018) |
Jerry Monzu | Joint Company Secretary | 23 Apr 2019 | See above |
“—” = not publicly disclosed.
Directors' Remuneration
| KMP | Salary and fees | Other | Super | Share-based | Total | % performance-related |
|---|---|---|---|---|---|---|
Mark Pearce | 12,667 | 0 | 1,520 | 506,850 | 521,037 | 97 |
Tom Corr | 60,000 | 27,000 | 0 | 506,850 | 593,850 | 85 |
Peter Huljich | 60,000 | 0 | 0 | 120,000 | 180,000 | 67 |
Julian Barnes | 37,503 | 0 | 0 | 0 | 37,503 | 0 |
Jerry Monzu | 15,298 | 48,081 | 0 | 0 | 63,379 | 0 |
Greg Ross | 68,182 | 0 | 8,182 | 98,013 | 174,377 | 56 |
Greg Swan | 0 | 0 | 0 | 225,000 | 225,000 | 100 |
Martijn Cysouw | 9,475 | 0 | 0 | 0 | 9,475 | 0 |
Total | 263,125 | 75,081 | 9,702 | 1,456,713 | 1,804,621 | — |
Governance Overview
| Attribute | Assessment |
|---|---|
Size | 4 directors, all non-executive; no executive director (CEO not on board) |
Chair/CEO separation | Yes |
Independence | Formally all NEDs, but analyst view: Pearce's related entity (Apollo Group) is a material service provider (~A$270k p.a.); Corr's related entity receives advisory fees and Corr is a founding/substantial shareholder; both hold large incentive packages. Barnes appears the most clearly independent director. Huljich holds incentives and subscribed in the placement |
Committees | None — the FY2026 AR states there were no Board committees during the year (functions performed by full Board) |
Meetings FY2026 | 9 board meetings; full attendance by all eligible directors |
Corporate governance statement | Published separately (FY2025 statement lodged 22 Sep 2025; FY2026 per AR p.61) |
Diversity | All-male board and executive team (per disclosed names) |
Major Shareholders
| Holder | Ordinary shares | % of 1,285.0M (30 Jun 2026) | Notes |
|---|---|---|---|
Tom Corr | 46,999,999 | 3.66 | Plus 15.3m rights, 40m options |
Martijn Cysouw (Meclex) | 35,634,911 | 2.77 | Plus 252.3m options/rights (vendor-related) |
Mark Pearce (via Roseberry Holdings) | 25,000,000 | 1.95 | Plus 15.3m rights, 30m options |
Peter Huljich | 15,000,000 | 1.17 | Plus 5m rights, 5m options |
Greg Swan | 12,000,000 | 0.93 | Plus 20m options/rights |
Greg Ross | 5,000,000 | 0.39 | Plus 62.5m options/rights |
Total KMP | 139,634,910 | 10.87 | — |
Competitive Landscape
Competitors by Segment
| Activity | Competitor / alternative | Positioning vs ZMI |
|---|---|---|
ZLR processing (ARGO) | Incumbent pyrometallurgical residue treatment (Waelz kilns, fuming) operated by smelters | Entrenched; ARGO pitches lower energy/emissions and higher recoveries |
ZLR / by-product metals | Nyrstar (in-house processes; also ZMI partner) | Potential customer and potential competitor |
ZLR / by-product metals | Korea Zinc, Boliden, Glencore, Teck (Trail — Ge/In producer), Umicore | Large integrated players with own by-product recovery R&D |
Critical-mineral recovery | 5N Plus, Umicore (Ge/In refining) | Downstream refiners; potential offtakers or rivals |
Lead-acid recycling technology (VOLTA) | Aqua Metals (AquaRefining, US), ACE Green Recycling, other hydromet developers | Direct technology rivals pursuing smelter-less lead recycling |
Lead-acid recycling operators | Ecobat, Clarios, Gravita, Campine, SERI/FIB (partner) | Customers/licensees or competitors using pyrometallurgy |
Irish zinc exploration | Group Eleven Resources (TSXV), Arkle Resources, Boliden Tara (producing mine) | Peers on the Irish orefield; Boliden Tara is the producing benchmark |
Competitor Detail
| Metric | ZMI |
|---|---|
Revenue | 0 (FY2026) |
Revenue growth | n/m |
Operating margin | n/m |
R&D intensity | n/m |
Stage | Pre-revenue; TRL 4/6 |



